PIRU has been commissioned to undertake an evaluation of the UK Anti-Microbial Resistance (AMR) Strategy, 2013-18. The first stage of the evaluation is a scoping study to develop the questions, objectives and methods for the evaluation, and to identify the data and evidence sources to be used. The Strategy is very broad, containing many potentially interacting actions across many sectors, including human and animal health, and with an international dimension. A conventional evaluation of the impact of the Strategy, as would be appropriate to a single intervention, is not possible. Instead, the evaluation will comprise a study of the implementation of the Strategy and the key mechanisms of change identified in the Strategy, with a view to helping strengthen the Strategy in future.
The scoping study will identify the main areas of the Strategy to prioritise for evaluation since it will not be possible to analyse all aspects of the Strategy in equal depth. Crucially, the scoping study will also seek to define the underlying logic of the aims, areas and actions of the Strategy; describe the linked governance and implementation arrangements; and identify the sources of evidence that relate to both the outcomes sought by the Strategy and the mechanisms of change put in place to produce these outcomes.
A report from the scoping study, and model describing the underlying logic of the Strategy, will be produced Summer 2016.